trustmebro.to/r/…
✓ checked
trust me, bro:
here is the receipt.
the claim

Alzheimer's patients exhibit a deficiency in the neurotransmitter acetylcholine.

the verdict
SUPPORTED
the evidence backs this
Recorded sources
4 sources for · 0 against

Counts group repeated records of the same source within each side. They do not measure evidence strength or source independence.

Is it true that Alzheimer's patients exhibit a deficiency in the neurotransmitter acetylcholine?

Yes. Multiple studies and the foundational cholinergic hypothesis of Alzheimer's disease support the finding that patients exhibit a deficiency in the neurotransmitter acetylcholine.

Verdict: SUPPORTED · 4 sources for, 0 against · Last checked

The analysis

The retrieved literature consistently supports the long-standing cholinergic hypothesis of Alzheimer's disease, which posits that patients experience degeneration of cholinergic neurons and a consequential reduction in acetylcholine levels.

Evidence for · 4
Co-pathologies and biological processes beyond amyloid-beta and tau in people with Alzheimer's disease: Evidence from clinical cohort studies.
2026
Get citation
D, F., T, C., M, E., Jr, J. C., G, K., A, M., P, M., A, N., D, R., & E, W. (2026). Co-pathologies and biological processes beyond amyloid-beta and tau in people with Alzheimer's disease: Evidence from clinical cohort studies.. doi.org. https://doi.org/10.1111/joim.70096

See more details
More for · 3
Structure-Guided Optimization of 1,2,4-Triazole-Thione-Based Mannich Derivatives as Dual-Target Modulators: AChE/MAO-B.
2026
Get citation
HE, S., AB, A., H, Z., E, P. Y., BN, S. Ö., İS, D., & K, Ö. K. (2026). Structure-Guided Optimization of 1,2,4-Triazole-Thione-Based Mannich Derivatives as Dual-Target Modulators: AChE/MAO-B.. doi.org. https://doi.org/10.1111/cbdd.70347

Analysis of the Efficacy of Acetylcholinesterase Inhibitors in the Treatment of Alzheimer's Disease, Literature Review.
2026
Get citation
W, P., D, Ś., R, K., K, K., P, P., M, S., J, T., G, P., M, K., T, R., I, S., & A, C. (2026). Analysis of the Efficacy of Acetylcholinesterase Inhibitors in the Treatment of Alzheimer's Disease, Literature Review.. doi.org. https://doi.org/10.3390/ijms27135733

L-α-GPC in Cognitive Decline: Mechanisms and Clinical Evidence in Neurodegenerative Disorders.
2026
Get citation
VA, P., RS, H., & R, A. (2026). L-α-GPC in Cognitive Decline: Mechanisms and Clinical Evidence in Neurodegenerative Disorders.. doi.org. https://doi.org/10.2147/ndt.s579603

What does the evidence say?

The retrieved literature consistently supports the long-standing cholinergic hypothesis of Alzheimer's disease, which posits that patients experience degeneration of cholinergic neurons and a consequential reduction in acetylcholine levels.

Receipt History
Anyone with this link can read the claim and its public receipt, including any personal information in that text. Open permanent receipt.
Check your own claim
Challenge the receipt
Requests are recorded for review. This does not start an automatic check or guarantee a response time.

See the evidence timeline

Citation formatting by citeproc-js (Frank Bennett) and the Citation Style Language project. Source and licenses.

This receipt is an automated verdict against our published method · not an opinion about any author or publication.
Terms · Privacy · How verdicts work